CANC vs. HRTS ETF Comparison

Comparison of Tema Oncology ETF (CANC) to Tema Cardiovascular and Metabolic ETF (HRTS)
CANC

Tema Oncology ETF

CANC Description

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$27.01

Average Daily Volume

21,142

Number of Holdings *

8

* may have additional holdings in another (foreign) market
HRTS

Tema Cardiovascular and Metabolic ETF

HRTS Description Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$33.53

Average Daily Volume

21,843

Number of Holdings *

10

* may have additional holdings in another (foreign) market
Performance
Period CANC HRTS
30 Days -2.17% 2.41%
60 Days -1.71% 3.68%
90 Days -0.07% 1.45%
12 Months
2 Overlapping Holdings
Symbol Grade Weight in CANC Weight in HRTS Overlap
AMGN B 3.37% 5.54% 3.37%
MREO B 2.9% 2.84% 2.84%
CANC Overweight 6 Positions Relative to HRTS
Symbol Grade Weight
REGN B 5.72%
MRK C 5.26%
NVS A 3.17%
BPMC A 2.99%
ILMN D 2.92%
RVMD D 2.85%
CANC Underweight 8 Positions Relative to HRTS
Symbol Grade Weight
VRTX B -6.09%
LLY A -5.32%
NVO B -5.07%
DXCM D -3.95%
EW B -3.13%
NARI C -3.12%
PODD C -3.01%
MDT D -2.86%
Compare ETFs